Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope [0.03%]
临床争议：反射性晕厥心神经消融术的方法学和指征
Michele Brignole,Tolga Aksu,Leonardo Calò et al.
Michele Brignole et al.
Graphical AbstractObservational studies and a recent randomized controlled trial have provided some evidence that cardioneuroablation (CNA) may prevent syncope recurrence in patients affected by cardioinhibitory reflex syncope during the fi...
Dynamic changes in nocturnal heart rate predict short-term cardiovascular events in patients using the wearable cardioverter-defibrillator: from the WEARIT-France cohort study [0.03%]
夜间心率的动态变化可预测使用穿戴式除颤器患者的短期心血管事件：来自WEARIT-France队列研究的结果
Rodrigue Garcia,Peder Emil Warming,Kumar Narayanan et al.
Rodrigue Garcia et al.
Aims: While elevated resting heart rate measured at a single point of time has been associated with cardiovascular outcomes, utility of continuous monitoring of nocturnal heart rate (NHR) has never been evaluated. We hypo...
In atrial fibrillation epilepsy risk differs between oral anticoagulants: active comparator, nested case-control study [0.03%]
心房颤动抗凝药物不同癫痫风险：活性对照嵌套病例对照研究
Katharina Platzbecker,Helge Müller-Fielitz,Ronja Foraita et al.
Katharina Platzbecker et al.
Aims: Atrial fibrillation (AF) is a risk factor for brain infarction, which can lead to epilepsy. We aimed to investigate whether treatment of AF with direct oral anticoagulants (DOACs) affects the risk of epilepsy in com...
A John Camm
A John Camm
Atrial fibrillation (AF) is associated with life-threatening thromboembolism. Most emboli stem from thrombosis in the left atrial appendage (LAA). The current treatment of choice is oral anticoagulants (OACs), but a small proportion of pati...
Arrhythmogenic epicardial LA-PV connection at the peri-oesophageal posterior LA is safely and effectively blocked by ethanol infusion to the vein of Marshall [0.03%]
马歇尔静脉心房后部食管周围绕道左肺静脉的异位灶可通过酒精注射安全有效地阻断
Masateru Takigawa,Takashi Ikenouchi,Masahiko Goya et al.
Masateru Takigawa et al.
Exploiting SMART pass filter deactivation detection to minimize inappropriate subcutaneous implantable cardioverter defibrillator therapies: a real-world single-centre experience and management guide [0.03%]
SMART Pass滤波器停用监测在最小化不适当的心律失常疗法中的应用——单中心的真实世界经验及管理指南
Christopher Monkhouse,Amy Wharmby,Zoe Carter et al.
Christopher Monkhouse et al.
Aims: The SMART Pass™ (SP) algorithm is a high-pass filter that aims to reduce inappropriate therapy (IT) in subcutaneous internal cardiac defibrillator (S-ICD), but SP can deactivate due to low amplitude sensed R waves ...
Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants [0.03%]
联用抗心律失常药物和非维生素K拮抗剂口服抗凝药的心房颤动患者的临床结局
Victor Chien-Chia Wu,Chun-Li Wang,Yu-Chang Huang et al.
Victor Chien-Chia Wu et al.
Aims: Limited data compared antiarrhythmic drugs (AADs) with concomitant non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients, hence the aim of the study. ...
Early rhythm control for atrial fibrillation: looking cost-effective, at least from one direction [0.03%]
房颤早期节律控制：至少从一个角度看是符合成本效益的
Daniel P Morin
Daniel P Morin
The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale [0.03%]
生理室性起搏与管理室性起搏预防持续性房颤的临床疗效：生理室性起搏对阵（PhysioVP-AF研究）设计和意义
Gianni Pastore,Matteo Bertini,Carlo Bonanno et al.
Gianni Pastore et al.
Aims: In patients with prolonged atrioventricular (AV) conduction and pacemaker (PM) indication due to sinus node disease (SND) or intermittent AV-block who do not need continuous ventricular pacing (VP), it may be diffic...
Randomized Controlled Trial
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2023 May 19;25(5):euad082. DOI:10.1093/europace/euad082 2023
Atrial fibrillation progression: another step in the RACE to full understanding [0.03%]
房颤的发展：RACE研究进一步阐明了房颤的全貌
Alessandro Capucci,James A Reiffel
Alessandro Capucci
Graphical AbstractAtrial fibrillation progression: a clinical consequence of atrial fibrillation burden, concomitant comorbidities, and their duration.